31 Mar 2023
Assets32.31
Total Income32.03
EBITDA3.14
Profit After Tax1.57
NET Worth11.94
Reserves and Surplus14.78
Total Borrowing9.15
At a glance
Updated 2026-09-11Galaxy Medicare is a SME IPO with an issue size of ₹22.31 crore, proposed for listing on NSE SME. The issue structure includes a fresh issue of ₹16.74 crore and an offer-for-sale component of ₹4.45 crore.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹22.31 Cr
Fresh issue₹16.74 Cr
Offer for sale₹4.45 Cr
Face value₹10
Price band₹51.00–₹54.00
Allotment15th Sep 2025
Listing17th Sep 2025
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper price0.00%
Est. listing₹54.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens10th Sep 2025
Closes12th Sep 2025
Allotment15th Sep 2025
Refund16th Sep 2025
Demat16th Sep 2025
Listing17th Sep 2025
Subscription demand
Full bidding ↗Total1.83×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | ₹216,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha | ₹4.89 Cr |
| Funding the working capital requirements of the Company | ₹8.94 Cr |
| General Corporate Purposes | ₹2.25 Cr |
| To meet the Offer Related Expenses | ₹2.23 Cr |
| Total | ₹18.31 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue40.27₹ Cr · +9.0% vs prior year
EBITDA4.58₹ Cr · -12.9% vs prior year
PAT3.37₹ Cr · -9.2% vs prior year
Assets31.49₹ Cr · -3.2% vs prior year
Net Worth18.36₹ Cr · +18.1% vs prior year
Borrowing4.61₹ Cr · -43.2% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets32.53
Total Income36.94
EBITDA5.26
Profit After Tax3.71
NET Worth15.54
Reserves and Surplus9.51
Total Borrowing8.12
31 Mar 2025
Assets31.49
Total Income40.27
EBITDA4.58
Profit After Tax3.37
NET Worth18.36
Reserves and Surplus12.29
Total Borrowing4.61
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 19.88% |
| ROCE | 22.38% |
| Debt / Equity | 0.25% |
| RoNW | 18.35% |
| PAT Margin | 8.60% |
| EBITDA Margin | 11.69% |
| Price to Book Value | 3.49 |
Valuation & shareholding
Pre-IPO EPS2.84
Post-IPO EPS2.22
Pre-IPO P/E19.01
Post-IPO P/E24.31
Promoter holding pre99.57%
Promoter holding post72.43%
Market cap₹81.93 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Galaxy Medicare IPO | — | 23.96 x | — | — |
| Abh Healthcare IPO | — | 20.69 x | — | — |
| Credent Connect IPO | — | 153.66 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Book Running Lead Manager Fees | ₹1.35 Cr |
| Underwriting Fees | ₹0.55 Cr |
| Fees Payable to the Market Maker to the Issue | ₹0.03 Cr |
| Fees Payable to the Registrar to the Issue | ₹0.01 Cr |
| Fees Payable for Advertising and Publishing expenses | ₹0.10 Cr |
| Fees payable to Regulators including Stock Exchange and Depositories | ₹0.12 Cr |
| Payment fees for Printing & Stationery, Postages, etc | ₹0.00 Cr |
| Fees payable to Statutory Auditor, Legal Advisors and other Professionals | ₹0.03 Cr |
| Concurrent Auditor | ₹0.00 Cr |
| Others | ₹0.04 Cr |
Registrar & lead managers
Registrar
Cameo Corporate Services Ltd.Lead managers
- Affinity Global Capital Market...
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-11.
IPO UPDATE ALERTS
Register for IPO Updates →Track Galaxy Medicare without missing an update
Register for subscription, GMP, allotment and listing notifications.